Our in vivo experiments further demonstrated that miR-186 released from BMSC-EVs could reduce collagen and hydroxyproline contents and downregulate α-SMA and collagen I, suggesting its protective effect against IPF. This evidence concerns the gene ACTA1 and idiopathic pulmonary fibrosis.